Why Is HIMS & HERS HEALTH I A (HIMS) Stock Down Today?

HIMS stock is down 11.63% at $25.91 as of the latest trade following news that the Federal Trade Commission is planning to sue the company over alleged health data sharing with online advertisers. The lawsuit has sparked immediate investor concern, leading to a sharp decline in the stock’s value. The shares opened with a modest 0.7% gap down but quickly fell further, reaching a session low of $24.78 before stabilizing slightly.

What Happened

The U.S. Federal Trade Commission, along with the state of Utah, filed a lawsuit in federal court against Hims & Hers, alleging that the company improperly shared user health data with online advertisers including Meta and Snap. The company has responded by stating that the lawsuit disregards substantial evidence it provided to the FTC during its investigation and that it is confident in its position. The legal action has triggered a wave of selling pressure, with 14.5 million shares traded so far, nearly double the stock’s 3-month average daily volume.

What The Data Shows

The stock has been volatile in recent months, trading between $13.74 and $70.43 over the past 52 weeks. The recent 3-week decline has erased nearly 10.7% of its value, with the stock now trading at $25.91. Unusual options activity has also been noted, with $4.9 million in total premium traded over the last 36 hours, including a single notable print of $2.1 million. Retail traders have shown limited engagement, with only three social posts in the past 24 hours and one Reddit mention in the last seven days.

What To Watch

The company’s upcoming defense of its legal position will be closely monitored. Investors should also keep an eye on coverage breadth and any further developments in the legal case, as well as potential regulatory actions.